MK-7602

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MK-7602, covering 2025-01-13 to 2025-08-22. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the Effect Efavirenz on the Plasma Levels of MK-7602 in Healthy Participants (MK-7602-005) [Phase 1]